Article Versions Notes

Palles C, Fotheringham S, Chegwidden L, Lucas M, Kerr R, Mozolowski G, Rosmarin D, Taylor JC, Tomlinson I, Kerr D. An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities. Cancers. 2021; 13(7):1497. https://doi.org/10.3390/cancers13071497

Palles, Claire, Susan Fotheringham, Laura Chegwidden, Marie Lucas, Rachel Kerr, Guy Mozolowski, Dan Rosmarin, Jenny C. Taylor, Ian Tomlinson, and David Kerr. 2021. "An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities" Cancers 13, no. 7: 1497. https://doi.org/10.3390/cancers13071497

Palles, C., Fotheringham, S., Chegwidden, L., Lucas, M., Kerr, R., Mozolowski, G., Rosmarin, D., Taylor, J. C., Tomlinson, I., & Kerr, D. (2021). An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities. Cancers, 13(7), 1497. https://doi.org/10.3390/cancers13071497